Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01712659
Title Ruxolitinib for Adult T-Cell Leukemia
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

adult T-cell leukemia/lymphoma

Therapies

Ruxolitinib

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda Maryland 20892 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field